↓ Skip to main content

Current and emerging therapies in primary myelofibrosis.

Overview of attention for article published in Cardiovascular & Haematological Disorders - Drug Targets, September 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
3 X users

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Current and emerging therapies in primary myelofibrosis.
Published in
Cardiovascular & Haematological Disorders - Drug Targets, September 2012
DOI 10.2174/187152912801823174
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 5 24%
Researcher 4 19%
Other 3 14%
Student > Bachelor 2 10%
Student > Postgraduate 2 10%
Other 3 14%
Unknown 2 10%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 8 38%
Biochemistry, Genetics and Molecular Biology 3 14%
Agricultural and Biological Sciences 3 14%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Business, Management and Accounting 1 5%
Other 3 14%
Unknown 2 10%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2012.
All research outputs
#23,329,605
of 34,410,315 outputs
Outputs from Cardiovascular & Haematological Disorders - Drug Targets
#82
of 165 outputs
Outputs of similar age
#160,336
of 226,187 outputs
Outputs of similar age from Cardiovascular & Haematological Disorders - Drug Targets
#2
of 7 outputs
Altmetric has tracked 34,410,315 research outputs across all sources so far. This one is in the 30th percentile – i.e., 30% of other outputs scored the same or lower than it.
So far Altmetric has tracked 165 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,187 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.